跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SODIUM CHLORIDE KABI SOLUTION FOR INFUSION 0.9% - HSA Drug Approval Details
Approvals
/
HSA
/
SODIUM CHLORIDE KABI SOLUTION FOR INFUSION 0.9%
Approved
THERAPEUTIC
SODIUM CHLORIDE KABI SOLUTION FOR INFUSION 0.9%
Fresenius Kabi Vietnam Joint Stock Company
🇸🇬 Health Sciences Authority
Approval Date
Apr 4, 2017
Approval ID
39ebc1f8d1b49e23
Company
Fresenius Kabi Vietnam Joint Stock Company
Type
Therapeutic
Approval Details
Approval Id
39ebc1f8d1b49e23
Drug Name
SODIUM CHLORIDE KABI SOLUTION FOR INFUSION 0.9%
Product Name
SODIUM CHLORIDE KABI SOLUTION FOR INFUSION 0.9%
Approval Number
SIN15205P
Approval Date
2017-04-04
Registrant
FRESENIUS KABI (SINGAPORE) PTE LTD
Licence Holder
FRESENIUS KABI (SINGAPORE) PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INFUSION, SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
B05XA03
Atc Item Name
sodium chloride
Pharma Manufacturer Name
FRESENIUS KABI (SINGAPORE) PTE LTD
Company Detail Path
/organization/fresenius-kabi-singapore-pte-ltd
Active Ingredients
Sodium chloride
0.9%
SODIUM CHLORIDE
0.9%
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Apr 4, 2017
Approval ID
39ebc1f8d1b49e23
Type
Therapeutic
Back to HSA Approvals
